The estimated Net Worth of Joseph A Mollica is at least $6.97 Millón dollars as of 12 April 2017. Joseph Mollica owns over 20,000 units of Neurocrine Biosciences stock worth over $6,966,790 and over the last 21 years Joseph sold NBIX stock worth over $0.
Joseph has made over 5 trades of the Neurocrine Biosciences stock since 2013, according to the Form 4 filled with the SEC. Most recently Joseph exercised 20,000 units of NBIX stock worth $68,000 on 12 April 2017.
The largest trade Joseph's ever made was exercising 20,000 units of Neurocrine Biosciences stock on 12 April 2017 worth over $68,000. On average, Joseph trades about 4,091 units every 67 days since 2003. As of 12 April 2017 Joseph still owns at least 57,354 units of Neurocrine Biosciences stock.
You can see the complete history of Joseph Mollica stock trades at the bottom of the page.
Joseph's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Neurocrine Biosciences have traded over $159,913,426 worth of Neurocrine Biosciences stock and bought 103,400 units worth $589,660 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... y Richard F Pops. On average, Neurocrine Biosciences executives and independent directors trade stock every 8 days with the average trade being worth of $1,567,813. The most recent stock trade was executed by William H Rastetter on 15 August 2024, trading 14,250 units of NBIX stock currently worth $2,090,333.
neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders
Neurocrine Biosciences executives and other stock owners filed with the SEC include: